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Summary
BACKGROUND: Multiple risk prediction models have
been validated in all-age patients presenting with acute
coronary syndrome (ACS) and treated with percutaneous
coronary intervention (PCI); however, they have not been
validated specifically in the elderly.
METHODS: We calculated the GRACE (Global Registry
of Acute Coronary Events) score, the logistic EuroSCORE,
the AMIS (Acute Myocardial Infarction Swiss registry)
score, and the SYNTAX (Synergy between Percutaneous
Coronary Intervention with TAXUS and Cardiac Surgery)
score in a consecutive series of 114 patients ≥75 years
presenting with ACS and treated with PCI within 24 hours
of hospital admission.
Patients were stratified according to score tertiles and ana-
lysed retrospectively by comparing the lower/mid tertiles
as an aggregate group with the higher tertile group. The
primary endpoint was 30-day mortality. Secondary end-
points were the composite of death and major adverse car-
diovascular events (MACE) at 30 days, and 1-year MACE-
free survival. Model discrimination ability was assessed
using the area under receiver operating characteristic curve
(AUC).
RESULTS: Thirty-day mortality was higher in the upper
tertile compared with the aggregate lower/mid tertiles ac-
cording to the logistic EuroSCORE (42% vs 5%; odds ratio
[OR] = 14, 95% confidence interval [CI] = 4–48; p <0.001;
AUC = 0.79), the GRACE score (40% vs 4%; OR = 17,
95% CI = 4–64; p <0.001; AUC = 0.80), the AMIS score
(40% vs 4%; OR = 16, 95% CI = 4–63; p <0.001; AUC =
0.80), and the SYNTAX score (37% vs 5%; OR = 11, 95%
CI = 3–37; p <0.001; AUC = 0.77).
CONCLUSIONS: In elderly patients presenting with ACS
and referred to PCI within 24 hours of admission, the
GRACE score, the EuroSCORE, the AMIS score, and the
SYNTAX score predicted 30 day mortality. The predictive
value of clinical scores was improved by using them in
combination.
Key words: acute coronary syndrome; PCI; SYNTAX;
EuroSCORE; GRACE score; AMIS score
Introduction
Primary percutaneous coronary intervention (PCI) is com-
monly performed in patients presenting with ST-segment
elevation myocardial infarction (STEMI). In addition, it
is performed in a large subset of patients presenting with
an acute coronary syndrome (ACS) other than STEMI,
including non-ST-segment elevation myocardial infarction
(NSTEMI) and unstable angina [1]. Identifying high-risk
patients among those presenting with ACS has far reaching
clinical consequences [2]. Thus, multiple patient-based risk
prediction models have been validated in all-age popula-
tions of patients presenting with ACS and referred to PCI.
Most of these models rely largely or entirely on clinical
variables [3–6]. The GRACE (Global Registry of Acute
Coronary Events) score was validated in more than 20,000
patients recruited between 1999 and 2003. This score pre-
dicted mortality at six months in patients discharged after
an ACS episode [3]. Its use for risk stratification in ACS
was recommended by clinical practice guidelines [7]. The
logistic EuroSCORE (European System for Cardiac Oper-
ative Risk Evaluation) originally was validated as a method
of predicting the mortality risk during, or shortly after,
heart surgery [8]. Subsequently, this score was validated in
patients referred for other cardiovascular interventions in-
cluding PCI with unprotected left main disease [9–11] or
multivessel coronary artery disease [12]. The AMIS (Acute
Myocardial Infarction [AMI] in Switzerland) risk score
was developed within the context of the AMIS Plus Nation-
al Registry [13] and includes seven clinical variables. It ac-
curately predicted intra-hospital mortality in AMI patients
(C statistics = 0.842) [14].
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The SYNTAX (Synergy between Percutaneous Coronary
Intervention with TAXUS and Cardiac Surgery) score was
developed as a comprehensive approach for the prospective
quantification of coronary lesions with respect to their
number, location, and anatomical complexity [15, 16]. This
anatomical score was pioneered to aid in decision making
in patients with complex coronary artery disease (CAD)
allocated to PCI or coronary artery bypass graft (CABG)
surgery in the landmark SYNTAX trial [16]. Subsequently,
the SYNTAX score was validated for risk prediction in pa-
tients referred for PCI with multivessel disease [17–18] or
unprotected left main disease [19–22], as well as in the
general population undergoing PCI [23] and in patients
with STEMI [24, 25] or NSTEMI undergoing PCI [26]. As
such, the SYNTAX score is advocated in European and US
guidelines as a tool to help clinicians decide the optimum
revascularisation approach in patients with complex CAD.
Elderly patients presenting with ACS are a high risk group
[27]. While most studies of risk prediction models in ACS
patients have been carried out in all-age groups, elderly pa-
tients were under-represented in these studies. If not ex-
cluded by age, numerous elderly patients were excluded
from these studies because of existing co-morbidities or
other serious systemic illnesses.
Unfortunately, data on risk prediction in the elderly
presenting with ACS and referred for PCI are scarce. We
recently reported that the SYNTAX score predicted early
mortality in elderly patients presenting with ACS and re-
ferred for PCI within 24 hours of admission to the hospital
[28]. Here, we compared the predictive value of clinical
scores including the GRACE score, the logistic Eur-
oSCORE, and the AMIS score with the SYNTAX score in
this group of patients.
Methods
Study population
All patients ≥75 years who were admitted to our institution
with ACS during 2007 and 2008, had no exclusion criteria,
and were treated by PCI within 24 hours of hospital ad-
mission were included in a retrospective analysis. ACS and
STEMI were defined according to the guidelines of the
European Society of Cardiology [29–31]. Exclusion criter-
ia included previous CABG surgery or clinical indication
for emergent CABG surgery; however, they did not include
previous PCI. The decision to perform PCI, to treat addi-
tional coronary lesions beyond the infarct-related lesion,
and to implant bare metal stents (BMS) or drug eluting
stents (DES) was at the discretion of the operator. There
was no restriction on the number of implanted stents.
Score systems
The logistic EuroSCORE includes cardiac-related factors
(unstable angina, LV function, recent myocardial infarc-
tion, pulmonary hypertension), other patient-related vari-
ables (age, gender, chronic pulmonary disease, peripheral
artery disease, neurological disease, previous cardiac sur-
gery, serum creatinine >200 microm/l, active endocarditis,
critical preoperative state), and procedure-related variables
(emergency other than isolated CABG, surgery on thoracic
aorta, post-infarct septal rupture) [8]. The score was cal-
culated using an online calculator (ht-
tp://www.euroscore.org).
The GRACE score includes several conditions such as age,
Killip-class, systolic blood pressure, heart rate, serum cre-
atinine, cardiac arrest at admission, ST-segment deviation,
and elevated serum levels of cardiac enzymes [3].
The AMIS risk score includes seven clinical variables (age,
gender, systolic blood pressure and heart rate on admission,
Killip-class, pre-hospital resuscitation, history of heart fail-
ure, history of cerebrovascular disease/stroke) [13, 14].
This score was determined using an online calculator
(http://www.amis-plus.ch/amis_risk_model.htm).
The SYNTAX score was calculated by scoring separately,
from the baseline angiogram, each coronary lesion causing
>50% diameter stenosis in vessels >1.5 mm in diameter,
and then adding together the individual scores using the
SYNTAX score online calculator (ht-
tp://www.syntaxscore.com) [15]. For each patient, all an-
giographic variables involved in the calculation of the
SYNTAX score were computed by two independent in-
vestigators who were blinded to all clinical data. Because
patients with STEMI were excluded from the initial
SYNTAX score algorithm [15, 16], there currently is no
extensively validated method of calculating the score in
STEMI patients. We therefore followed a method used for
this purpose in recent studies in STEMI patients [24, 25]. If
the infarct-related artery was occluded, it was scored as an
occluded artery of <3 months’ duration.
Data collection
Baseline data were assessed retrospectively. Patients were
invited to a 12 month follow-up interview, which was per-
formed using a standardised protocol. They agreed to par-
ticipate in the interview, and to have their clinical data col-
lected and used for statistical analyses within the scope of
the study. No ethical approval was required for this obser-
vational study. The patients’ out-hospital caring physicians
were contacted by phone. Hospital admissions and ma-
jor adverse cardiovascular events (MACE), defined as the
composite of death, target vessel revascularisation, AMI
and stroke after baseline PCI were monitored. All docu-
ments regarding hospital admissions, out-hospital medical
examinations, and fatal events were collected.
Statistical methods
Data were described as mean and standard deviation (SD)
if continuous, and as counts and % if categorical (tables
1 and 2). They were compared between score groups by
means of the test for trend.
Analyses of death or MACE at 30 days: The predictive role
of the logistic EuroSCORE, the GRACE score, the AMIS
score, and the SYNTAX score with respect to mortality at
30 days, the study’s primary end point, or rates of MACE at
30 days, one of the two secondary end points of the study,
was assessed with the logistic model, both with scores on
a continuous scale and categorised as the aggregate lower/
mid vs upper tertile (defined as the "high-risk" tertile). Ter-
tile categorisation reflects the clinical practice of identify-
ing high risk patients. Aggregating lower and mid tertiles
into a single group was used in order improve the statistic-
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al power of the analysis. In addition, a combined score was
computed by adding up the number of score models ac-
cording to which a patient was classified in the “highrisk”
tertile. To assess the predictive accuracy (discrimination
ability) of scores, we computed the areas under the receiver
operator characteristic (ROC) curves (and 95% confidence
intervals; CI) and compared them between models. Be-
cause combinations of models are of interest when the in-
dividual models do not significantly overlap, we computed
the Kappa statistic (and standard error) and the Lin’s con-
cordance correlation coefficient (with 95% CI) to measure
the agreement of any two scores.
Analysis of MACE at one year: Rates of MACE at one year,
one of the study’s secondary end points, was described by
means of the Kaplan-Meier method (in terms of event-free
survival) and compared between groups with a Cox model.
Follow-up was computed from the time point of PCI. The
Harrell’C statistic (with 95% CI) was computed to measure
model discrimination ability (highest discrimination abil-
ity, Harrell’C value = 1) and compare models. Stata 13
(College Station, TX, USA) was used for computation. A
two-sided p <0.05 value was considered statistically signi-
ficant.
Results
Risk scores
Clinical scores were calculated in a series of 114 consecut-
ive patients aged ≥75 (mean age, 79.6 ± 4.1) who presented
with ACS during 2007 and 2008, had no exclusion criter-
ia, and were treated with PCI within 24 hours of hospital
admission. No patient was lost during follow-up. Clinical
characteristics of the study population as a whole or strat-
ified according to each clinical score are shown in table
1. STEMI was diagnosed in 76.3% of patients. Cardiogen-
ic shock and cardiac arrest were diagnosed in 16.7% and
12.3% of patients, respectively. The logistic EuroSCORE
(mean ± SD) was 34.9 ± 17.9 in the overall population,
56.2 ± 14.0 in the higher tertile, and 24.5 ± 7.1 in the ag-
gregate lower/mid tertiles. The GRACE score was 19.5 ±
22.4 in the overall population, 45.2 ± 23.8 in the higher ter-
tile, and 7.3 ± 3.6 in the lower/mid tertiles. The AMIS score
was 19.9 ± 26.9 in the overall population, 50.5 ± 27.8 in the
higher tertile, and 4.5 ± 2.8 in the lower/mid tertiles. The
Figure 1
Boxplot showing the distribution of the log EuroSCORE, the
GRACE score, the AMIS score, and the SYNTAX score in the study
population; boxes represent the 25th and 75th percentile and
midlines represent the median; whiskers represent the range
excluding the extreme outliers (±3D), which are shown as dots.
Table 1: Baseline clinical characteristics of the study population either non-stratified or stratified in the higher and the aggregate lower/mid tertiles according to the clinical
scores (log EuroSCORE, GRACE score, AMIS score).
Overall
population n
= 114
Log EuroSCORE
Overall population (34.9 ± 17.9)
n = 113
GRACE Score
Overall population (19.5 ± 22.4)
n = 114
AMIS Score
Overall population (19.9 ± 26.9)
n = 112
Lower/mid
tertiles (24.5
± 7.1)
Higher
tertile
(56.2 ± 14.0)
p Lower/mid
tertiles (7.3 ±
3.6)
Higher
tertile
(45.2 ± 23.8)
p Lower/mid
tertiles (4.5 ±
2.8)
Higher
tertile
(50.5 ± 27.8)
p
n = 82 n = 31 n = 79 n = 35 n = 77 n = 35
Age, mean (SD) 79.6 ± 4.1 79.1 ± 3.8 80.7 ± 4.3 0.028 79.0 ± 3.8 80.9 ± 4.3 0.07 79.2 ± 4.0 80.5 ± 4.1 0.12
Male sex, n (%) 76 (66.7) 55 (67.0) 20 (64.5) 0.798 54 (67.5) 22 (64.7) 0.773 51 (65.3) 24 (68.5) 0.74
Diabetes, n (%) 23 (22.3) 14 (19.1) 8 (27.5) 0.354 12 (17.1) 11 (33.3) 0.067 10 (14.2) 13 (40.6) 0.003
Hypertension, n (%) 80 (72.0) 61 (76.2) 18 (60.0) 0.093 57 (73.0) 23 (69.7) 0.718 54 (71.5) 25 (73.5) 0.791
Current smoking, n (%) 11 (9.8) 8 (9.8) 3 (10.0) 0.899 9 (11.3) 2 (6.0) 0.438 9 (11.6) 1 (2.9) 0.531
Hyperlipidaemia, n (%) 48 (46.6) 36 (49.2) 12 (41.8) 0.471 36 (51.4) 12 (36.3) 0.155 31 (44.9) 17 (51.5) 0.535
Family history of CAD, n
(%)
16 (16.3) 14 (20.0) 2 (7.1) 0.122 13 (19.4) 3 (9.6) 0.228 12 (17.9) 4 (13.3) 0.577
Previous myocardial
infarction, n (%)
6 (12.5) 5 (15.1) 1 (7.1) 0.457 5 (13.9) 1 (8.3) 0.618 4 (11.4) 2 (15.3) 0.716
Previous PCI, n (%) 11 (9.7) 10 (12.2) 1 (3.2) 0.153 7 (8.7) 4 (11.7) 0.62 7 (8.9) 4 (11.4) 0.685
Renal insufficiency, n (%) 15 (13.2) 4 (4.8) 11 (35.5) 0.001 7 (8.7) 8 (23.5) 0.033 5 (6.4) 10 (28.5) 0.001
Peripheral vascular
disease, n (%)
5 (4.4) 3 (3.6) 2 (6.4) 0.521 5 (6.2) 0 (0) 0.138 5 (6.4) 0 (0) 0.127
Previous stroke, n (%) 4 (8.3) 1 (3.2) 3 (18.7) 0.074 2 (5.5) 2 (16.7) 0.233 1 (3.1) 3 (18.7) 0.068
COPD, n (%) 15 (13.2) 7 (8.5) 8 (25.8) 0.016 13 (16.2) 2 (5.8) 0.136 11 (14.1) 4 (11.4) 0.7
Sinus rhythm, n (%) 103 (92.0) 78 (96.3) 24 (80.0) 0.005 75 (94.9) 28 (84.8) 0.075 74 (94.8) 28 (84.8) 0.078
STEMI, n (%) 87 (76.3) 59 (71.9) 27 (87.1) 0.094 58 (72.5) 29 (85.2) 0.143 60 (76.9) 26 (74.3) 0.762
Cardiogenic shock, n (%) 19 (16.7) 3 (3.6) 16 (51.1) <0.001 0 (0) 19 (55.8) <0.001 2 (2.5) 17 (48.5) <0.001
Cardiac arrest, n (%) 14 (12.3) 2 (2.4) 12 (38.7) 0.001 1 (1.2) 13 (38.2) 0.001 2 (2.5) 12 (34.3) <0.001
SYNTAX score, mean (SD) 20.2 ± 10.8 18.5 ± 9.7 24.5 ± 12.4 0.017 17.9 ± 8.8 25.3 ± 12.9 0.001 18.2 ± 9.4 24.2 ± 12.5 0.01
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SYNTAX score was 20.2 ± 10.8 in the overall population,
32.8 ± 9.1 in the higher tertile, and 14.7 ± 5.6 in the lower/
mid tertiles. A boxplot showing the distribution of each
score in the study population is shown in figure 1. Cardio-
genic shock and cardiac arrest, but not STEMI, were signi-
ficantly more frequent in the higher tertile compared to the
lower/mid tertiles according to each score. Angiographic
data and PCI-related variables are shown in table 2. Three-
vessel disease was significantly more frequent in the high-
er tertile compared to lower/mid tertiles according to the
SYNTAX score (p<0.01). In patients with CTO, the ves-
Figure 2
Sensitivity vs specificity curves for the logEuroSCORE, the GRACE
score, the AMIS score, and the SYNTAX score with respect to the
study’s primary end point (30-day mortality). ROC areas for all
scores are indicated.
sel treated with PCI was another vessel than the chronic-
ally occluded one. Agreement between any two scores was
slight to fair on both the categorical and the continuous
scale, with the exception of the AMIS and GRACE scores
showing good agreement on both scales (table 5).
Risk scores and 30 day mortality
The study’s primary end point was mortality 30 days after
baseline PCI. Results in patients stratified according to in-
dividual risk scores are shown in table 3. Seventeen pa-
tients (14.9%) died within 30 days of PCI (15 in hospital
Figure 3
One-year MACE-free survival curves in patients stratified in the
higher and lower/mid tertiles according to log EuroSCORE (upper
right panel), the GRACE score (lower left panel), the AMIS score
(lower right panel), and the SYNTAX score (upper left panel).
Table 2: Angiographic and PCI-related data in the study population either non-stratified or stratified in the higher and the aggregate lower/mid tertiles according to the
SYNTAX score. Lesions include both treated and untreated lesions (≥50% stenosis). Chronic total occlusions (CTO) were not treated with PCI in the acute setting.
“Patients and number of stents” refers to numbers of patients receiving different numbers of stents. “Stent type” refers to numbers of patients receiving either DES or BMS
(in brackets, percentages of patients receiving a given stent type within the lower/mid or higher SYNTAX tertile groups).
Total
N = 114
SX low + intermediate
N = 79
SX high
N = 35
p
Infarct localisation
Anterior and antero-septal, n (%) 44 31 (40) 16 (43) 0.12
Inferior, n (%) 39 26 (34) 13 (35) 0.69
Posterior, n (%) 9 5 (6) 4 (11) 0.15
Lateral, n (%) 19 15 (20) 4 (11) 0.46
1, 2 or 3 vessel disease
1 vessel, n (%) 57 46 (59) 11 (32) <0.001
2 vessels, n (%) 34 25 (32) 9 (26) <0.001
3 vessels, n (%) 23 7 (9) 15 (42) <0.001
Chronic total occlusion (CTO), n (%) 12 (10.5) 5 (6.3) 7 (20.0) 0.12
Lesion localisation
Left main, n (%) 2 0 2 (3) 0.35
LAD, n (%) 79 53 (45) 26 (34) 0.44
RCX n, n (%) 53 31 (27) 22 (29) 0.02
RCA, n (%) 59 33 (28) 26 (34) <0.001
Patients and number of stents
0 stents, n (%) 7 6 (8) 1 (3)
1 stent, n (%) 69 50 (63) 19 (54)
2 stents, n (%) 30 21 (27) 9 (25)
3 stents, n (%) 5 2 (2) 3 (9)
4 stents, n (%) 3 0 3 (9)
Mean (SD) 1.4 ± 0.8 1.2 ± 0.6 1.7 ± 1.0 0.053
Stent type
Bare metal stents, n (%) 40 25 (34) 15 (42) 0.07
Drug eluting stents, n (%) 69 48 (66) 21 (58) 0.71
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and 2 post-discharge). Thirty-day mortality was signific-
antly higher (p <0.001) in the ”high risk” tertile compared
with the lower/mid tertiles calculated with each score mod-
el. AUC-ROC values using patients’ categorisation based
on score tertiles ranged from 0.77 for the SYNTAX score to
0.80 for the GRACE and AMIS scores. AUC-ROC values
using scores measured on the continuous scale ranged from
0.80 for the Logistic EuroSCORE to 0.85 for the SYNTAX
score (fig. 2).
Risk scores and MACE at 30 days
One of two secondary end points was rates of MACE
(the composite of deaths and nonfatal MACE) 30 days
after baseline PCI. Because only three patients had nonfatal
MACE over this time frame, results for these secondary
end points were similar to the primary end point: 30 day
MACE were significantly more frequent (p<0.001) in the
”high-risk” tertile compared with the lower/mid tertiles ac-
cording to each score tested. AUC ranged from 0.73 for the
logistic EuroSCORE to 0.79 for the AMIS score (data not
shown).
Risk scores and MACE at one year
Another secondary end point was rates of MACE one year
after baseline PCI. Twenty-four patients experienced a
MACE, including 20 deaths and 4 nonfatal MACE, during
this time frame. MACE-free survival at one year in patients
stratified according to the aggregate mid-lower tertiles vs
the higher tertile of all scores, measured on the continuous
scale, is shown in figure 3. Each score tested was able to
stratify patients into two significantly different risk groups.
In all cases, the predictive accuracy was good using both
categorised scores and scores measured on the continuous
scale (table 4).
Additional value of combining different scores
We hypothesised that combining different predictor vari-
ables would have additional value. Patients classified in the
”high-risk” group according to ≤2 scores were 88 (79%)
and those classified in the ‘high-risk’ group according to
3 and 4 scores were 11 (10%) and 12 (11%), respectively.
Thirty-day mortality was 3% in patients classified at ”high
risk” according to ≤2 scoring systems compared to 45%
and 75% in those classified at ”high risk” according to
3 and 4 scoring systems, respectively (OR for linear in-
crease across categories = 9.93, 95% CI = 4.13–23.87; p
<0.001; AUC = 0.88, 95% CI = 0.78–0.98). The combined
score showed higher predictive accuracy than each clinic-
al score, but not the SYNTAX score, as shown by AUC-
ROC values with scores measured on a continuous scale
(table 3; p <0.001 vs GRACE score; p = 0.007 vs logist-
ic EuroSCORE; p <0.001 vs AMIS score; p = 0.18 vs the
SYNTAX score).
Discussion
Various patient-based scoring algorithms have been val-
idated for risk stratification in patients referred for cardi-
ovascular interventions. While most of these algorithms are
based on clinical variables, the anatomical SYNTAX score
was validated recently in multiple clinical settings includ-
ing STEMI. However, many validation studies have been
carried out in all-age groups but not specifically in the eld-
erly [27]. Several studies have demonstrated that elderly
patients with ACS referred for PCI are at a higher risk
compared to younger patients. The GRACE investigators
showed that, among patients presenting with non-ST seg-
ment elevation ACS and referred for PCI or CABG, six
month mortality increased with age (1.6%, 4.3%, and 7.0%
Table 3: Mortality at 30 days in patients stratified in the higher and the aggregate lower/mid tertiles according to log EuroSCORE, the GRACE score, the AMIS score, and
the SYNTAX score (missing data regarding the AMIS score in one patient; AUC area under the curve; CI: confidence interval; OR: odds ratio). AUC values are shown for
scores both on a categorised and on a continuous scale.
Lower/mid tertiles Higher tertile OR 95% CI p AUC-ROC
(95%CI)
AUC-ROC
(95% CI)
[continuous]*
Mortality
Pts. n Deaths n (%) Pts. n Deaths n (%)
SYNTAXscore (n = 114) 79 4 (5.1) 35 13 (37.1) 11.08 3.28–37.13 <0.001 0.77
(0.66–0.88)
0.85
(0.74–0.95)
Logistic EuroSCORE (n = 113) 82 4 (4.9) 31 13 (41.9) 14.08 4.11–48.29 <0.001 0.79
(0.68–0.90)
0.80
(0.66–0.95)
GRACE score (n = 114) 79 3 (3.8) 35 14 (40.0) 16.89 4.43–64.32 <0.001 0.80
(0.70–0.91)
0.83
(0.69–0.97)
AMIS score (n = 112) 77 3 (3.9) 35 14 (40.0) 16.44 4.31–62.66 <0.001 0.80
(0.70–0.90)
0.82
(0.68–0.96)
* score expressed on a continuous scale
Table 4: MACE rates at one year (follow-up started at the time of PCI) in patients stratified in the higher and the aggregate lower/mid tertiles according to log EuroSCORE,
the GRACE score, the AMIS score, and the SYNTAX score (CI: confidence interval; HR: hazard ratio). Harrell’s c values are shown for scores both on a categorised and
on a continuous scale (*).
Low + intermediate high HR 95% CI p Harrell’s c (95%
CI)
Harrell’s c (95%
CI) [continuous]*
MACE
Total n MACCE
n (%)
Total n MACCE
n (%)
SYNTAX score, n (%) 73 9 (12.3) 34 15 (44.1) 4.65 2.03–10.65 <0.001 0.64 (0.57–0.77) 0.74 (0.63–0.85)
Logistic EuroSCORE 78 8 (10.3) 28 16 (57.1) 8.23 3.49–19.39 <0.001 0.76 (0.67–0.86) 0.79 (0.68–0.90)
Grace Score 73 8 (11.0) 34 16 (47.1) 5.85 2.49–13.71 <0.001 0.74 (0.65–0.83) 0.81 (0.71–0.90)
AMIS score 70 7 (10.0) 35 16 (45.7) 6.09 2.50–14.83 <0.001 0.75 (0.66–0.84) 0.83 (0.75–0.92)
* score expressed on a continuous scale
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in patients <70 years, 70–80 years, and >80 years, respect-
ively) [32]. In 47,407 consecutive patients who underwent
PCI and were prospectively enrolled in the PCI-Registry
of the EHS Programme, in-hospital mortality was 1.7% in
ACS patients <75 years compared to 5.2% in those ≥75
years [33]. Finally, data from the Zwolle Myocardial In-
farction Study Group showed that, among 6,746 consecut-
ive STEMI patients who had primary PCI between 1998
and 2008, 30 day mortality was 1.7% and 3.6% in men
and women <65 years, respectively, compared to 6.4% and
9.6% in men and women ≥65 years, respectively [34].
Here, we evaluated three risk scores based on clinical para-
meters (the logistic EuroSCORE, the GRACE score and
the AMIS score) and the angiographic SYNTAX score for
risk stratification in the elderly presenting with ACS and
treated with PCI within 24 hours of hospital admission.
All four scoring systems predicted mortality at 30 days,
the study’s primary end point, with fair-to-good discrimin-
ation (AUC values: 0.80 to 0.85 with scores on a continu-
ous scale; 0.77 to 0.80 with scores categorised). An advant-
age of clinical scores over the anatomical SYNTAX score
is that the former can be calculated ahead of coronary an-
giography.
There was limited statistical agreement between the differ-
ent scores tested in the present study (supplemental table
1), implying limited overlap between risk categories
defined by different score models. This observation raised
the question as to whether being at a high risk according
to multiple scores was associated with a higher actual risk
compared to being at a high risk according to just one or
two scores. Mortality at 30 days was 3% in patients who
were in the higher tertile according to ≤2 scores, 45% in
those who were in the higher tertile according to three
scores, and 75% in those who were in the higher tertile
according to four scores. The discrimination ability of the
combined score model was excellent (AUC 88%) and sig-
nificantly superior to that of each clinical score used indi-
vidually; however, confirmatory studies in larger popula-
tions are needed.
All four scores accurately stratified MACE-free survival
after 12 months of follow-up. Most events took place in the
first month after PCI, however, indicating that elderly pa-
tients with ACS discharged alive after PCI had relatively
good outcomes.
Direct comparisons of clinical scoring systems with the
SYNTAX score in PCI patients are scarce. Garg et al.
[35] reported a modest yet significant difference between
the ACEF (Age, serum Creatinine, and Ejection Fraction)
score, the SYNTAX score, and the clinical SYNTAX score
(a combination of a modified ACEF score and the
SYNTAX score) for prediction of 5 year mortality (C-stat-
istics: 0.65, 0.62, and 0.69, respectively) and MACE (C-
statistics: 0.57, 0.59, and 0.62, respectively) in patients
presenting with complex coronary disease and stable or un-
stable angina or silent ischaemia, who were referred for
PCI. Another study by the same group [24] showed a high-
er predictive value for the clinical PAMI (Primary An-
gioplasty in Myocardial Infarction) score compared with
the SYNTAX score with respect to one year mortality (C
statistics: 0.81 and 0.65, respectively) and MACE (C-stat-
istics: 0.68 and 0.64, respectively) in STEMI patients
treated by PCI. Palmerini et al. [36] compared the GRACE
score, the New Risk Stratification score (NERS), the ACEF
score, the Thrombolysis in Myocardial Infarction (TIMI)
score, the SYNTAX score and the clinical SYNTAX score
(CSS) in patients with non-ST elevation ACS. The NERS,
the SYNTAX score and the CSS were the only scores
showing both good discrimination and calibration for car-
diac mortality at one year. Scores incorporating clinical and
angiographic variables (CSS and NERS) showed the best
trade-off between discrimination and calibration for most
end points. Most recently, patient-level merged data from
>6,000 patients in seven contemporary coronary stent trials
was used to develop a logistic regression model, the Logist-
ic Clinical SYNTAX score, to predict one year outcomes
[37]. A core model (composed of the SYNTAX score, age,
creatinine clearance, and LVEF) and an extended model
(incorporating the core model and six additional, best per-
forming clinical variables) were developed and validated.
The core model demonstrated a substantial improvement in
predictive ability for one year any cause death compared
with the SYNTAX score alone (AUC: 0.753 vs 0.660). The
core model alone therefore was retained in the final Lo-
gistic Clinical SYNTAX score model. Recently, a combin-
ation of anatomical and clinical factors in SYNTAX score
II was shown to predict long-term ( four year) mortality in
patients with complex CAD and to better guide decision
making between CABG and PCI than the original anatom-
ical SYNTAX score [38].
An important feature in the elderly which was not specific-
ally addressed by the scoring systems used in the present
study is frailty, as described by Fried and coworkers [39].
A recent study of 628 non-ACS patients ≥65 years not
presenting with ACS and discharged after PCI showed a
three year mortality of 28% for frail patients compared
to 6% for non-frail patients [40]. After adjustment, frailty
(HR, 4.19; 95% CI, 1.85–9.51) was associated with mortal-
ity.
Table 5: Kappa Agreement and Lin’s concordance correlation coefficient (Rho-c) between clinical scores (log EuroSCORE, GRACE score, AMIS score) and the SYNTAX
score.
Syntax score (n = 114) Log EuroSCORE (n = 113) GRACE score (n = 114) AMIS score (n = 112)
Kappa (SE) 0.14 (0.09) 0.34 (0.09) 0.22 (0.09)
Lin’s Rho-c (95% CI) 0.18 (0.06–0.30) 0.33 (0.20–0.45) 0.24 (0.12–0.36)
AMIS score Log EuroSCORE GRACE score
Kappa (SE) 0.46 (0.09) 0.73 (0.09) –
Lin’s Rho-c (95% CI) 0.50 (0.39–0.50) 0.90 (0.86–0.93) –
Log EuroSCORE GRACE score
Kappa (SE) 0.55 (0.09) –
Lin’s Rho-c (95% CI) 0.52 (0.41–0.62) –
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It should be emphasised that the low sample size included
represents a major limitation of our analysis, and therefore
the prognostic values of different scores could not be as-
sessed precisely. Nevertheless, the prognostic value of all
scores tested was demonstrated at a statistically significant
level. It also should be noted that the scores used in this
study were originally developed for different purposes: the
GRACE score for predicting six month mortality in pa-
tients discharged after an ACS episode [3], the euroSCORE
for quality assessment of cardiac surgical care [8], the
AMIS score for risk estimation of in-hospital mortality [13,
14], the SYNTAX as an angiographic tool grading the com-
plexity of coronary lesions to predict prognosis and out-
come at different time points [15, 16]. Finally, limitations
of the SYNTAX score in patients with acute vessel occlu-
sions were addressed previously [24, 25].
In conclusion, our data indicate that several clinical risk
scores as well as the angiographic SYNTAX score predict
mortality and MACE at 30 days in elderly patients present-
ing with ACS and referred for PCI within 24 hours of ad-
mission. Risk assessment can be improved by using mul-
tiple clinical scores in combination.
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Figures (large format)
Figure 1
Boxplot showing the distribution of the log EuroSCORE, the GRACE score, the AMIS score, and the SYNTAX score in the study population;
boxes represent the 25th and 75th percentile and midlines represent the median; whiskers represent the range excluding the extreme outliers
(±3D), which are shown as dots.
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Figure 2
Sensitivity vs specificity curves for the logEuroSCORE, the GRACE score, the AMIS score, and the SYNTAX score with respect to the study’s
primary end point (30-day mortality). ROC areas for all scores are indicated.
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Figure 3
One-year MACE-free survival curves in patients stratified in the higher and lower/mid tertiles according to log EuroSCORE, the GRACE score,
the AMIS score, and the SYNTAX score.
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